Carcinosarcoma Maxillary Sinus: A Rare Case Report with Review of Literature

被引:0
作者
Puthiyottil, Sanudev Sadanandan Vadakke [1 ]
Jabir, K. Mohamed [1 ]
Edayattil, Arathi [1 ]
Suprya, N. K. [2 ]
Suma, R. [3 ]
Abdurahman, Amina [4 ]
机构
[1] Govt Med Coll, Dept Med Oncol, Kozhikode 673008, Kerala, India
[2] Govt Med Coll, Dept Pathol, Kozhikode, Kerala, India
[3] Govt Med Coll, Dept Otorhinolaryngol, Kozhikode, Kerala, India
[4] Govt Med Coll, Dept Radiat Oncol, Kozhikode, Kerala, India
关键词
carcinosarcoma; maxillary sinus; case report; sarcomatoid carcinoma; pseudosarcoma; SQUAMOUS-CELL CARCINOMA; SARCOMATOID CARCINOMA; MESENCHYMAL TRANSITION; HEAD; CHEMOTHERAPY; NECK; MANAGEMENT; CETUXIMAB; RECURRENT;
D O I
10.1055/s-0044-1792130
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Carcinosarcoma of maxillary sinus is an extremely rare type of cancer in the head and neck region. It is an aggressive tumor compared with other head and neck malignancies. An 85-year-old male evaluated for left nasal obstruction, swelling at the root of the nose, and epistaxis. On evaluation with nasal endoscopy, computed tomography (CT) and magnetic resonance imaging showed an enhancing proliferative soft tissue mass, involving the left nasal cavity, with destruction of the left frontal bone, extending up to the medial wall of the orbit. Biopsy showed a biphasic tumor with malignant squamous and sarcomatoid areas. He underwent medial maxillectomy and histology report was consistent with carcinosarcoma, with positive margins. Repeat CT showed gross residual disease. The patient was treated with palliative radiotherapy in view of advanced age, multiple comorbidities, and poor performance status and poor general health. He tolerated the treatment well. Surgery with or without adjuvant radiation is the mainstay of treatment. There is no role of adjuvant chemotherapy as of now. Chemotherapy can be tried in neoadjuvant or palliative setting. Radiotherapy can be delivered for postsurgical palliation of local recurrence. Palliative radiotherapy can be offered when no other options are available or not tolerated, or to relieve symptoms, or to treat the metastases, or in case of recurrent disease. There is no evidence for role of immunotherapy or targeted agents in the neoadjuvant or adjuvant setting. Molecular studies may pave way to the future therapeutic options for this rare variant.
引用
收藏
页数:7
相关论文
共 30 条
[1]   Management of Spindle Cell Carcinoma of the Maxillary Sinus: A Case Report and Literature Review [J].
Alem, Hisham B. ;
AlNoury, Mohammed K. .
AMERICAN JOURNAL OF CASE REPORTS, 2014, 15 :454-458
[2]   Maxillary carcinosarcoma: Identification of a novel MET mutation in both carcinomatous and sarcomatous components through next generation sequencing [J].
Ando, Mizuo ;
Saito, Yuki ;
Morikawa, Teppei ;
Omura, Go ;
Kobayashi, Kenya ;
Akashi, Ken ;
Yoshida, Masafumi ;
Ebihara, Yasuhiro ;
Fujimoto, Chisato ;
Fukayama, Masashi ;
Yamasoba, Tatsuya ;
Asakage, Takahiro .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (12) :E179-E185
[3]  
[Anonymous], ?About us"
[4]   Immunohistochemical p53 expression patterns in sarcomatoid carcinomas of the upper respiratory tract [J].
Ansari-Lari, MA ;
Hoque, MO ;
Califano, J ;
Westra, WH .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (08) :1024-1031
[5]   Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer [J].
Arumugam, Thiruvengadam ;
Ramachandran, Vijaya ;
Fournier, Keith F. ;
Wang, Huamin ;
Marquis, Lauren ;
Abbruzzese, James L. ;
Gallick, Gary E. ;
Logsdon, Craig D. ;
McConkey, David J. ;
Choi, Woonyoung .
CANCER RESEARCH, 2009, 69 (14) :5820-5828
[6]   Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study [J].
Burtness, Barbara ;
Harrington, Kevin J. ;
Greil, Richard ;
Soulieres, Denis ;
Tahara, Makoto ;
de Castro, Gilberto, Jr. ;
Psyrri, Amanda ;
Baste, Neus ;
Neupane, Prakash ;
Bratland, Ase ;
Fuereder, Thorsten ;
Hughes, Brett G. M. ;
Mesia, Ricard ;
Ngamphaiboon, Nuttapong ;
Rordorf, Tamara ;
Ishak, Wan Zamaniah Wan ;
Hong, Ruey-Long ;
Mendoza, Rene Gonzalez ;
Roy, Ananya ;
Zhang, Yayan ;
Gumuscu, Burak ;
Cheng, Jonathan D. ;
Jin, Fan ;
Rischin, Danny .
LANCET, 2019, 394 (10212) :1915-1928
[7]   Genomic landscape and tumor mutation burden analysis of Chinese patients with sarcomatoid carcinoma of the head and neck [J].
Chen, Hai-Bing ;
Gong, Xiao-Yang ;
Li, Wang ;
Chen, Dong-Sheng ;
Zhao, Le-le ;
Li, Si ;
Xiao, Ming-Zhe ;
Cheng, Lei ;
Chen, Xi .
ORAL ONCOLOGY, 2021, 121
[8]  
Cheong Jack P, 2014, Ear Nose Throat J, V93, pE1
[9]   Targeting EMT in cancer: opportunities for pharmacological intervention [J].
Davis, Felicity M. ;
Stewart, Teneale A. ;
Thompson, Erik W. ;
Monteith, Gregory R. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (09) :479-488
[10]   Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck [J].
Ferris, R. L. ;
Blumenschein, G., Jr. ;
Fayette, J. ;
Guigay, J. ;
Colevas, A. D. ;
Licitra, L. ;
Harrington, K. ;
Kasper, S. ;
Vokes, E. E. ;
Even, C. ;
Worden, F. ;
Saba, N. F. ;
Iglesias Docampo, L. C. ;
Haddad, R. ;
Rordorf, T. ;
Kiyota, N. ;
Tahara, M. ;
Monga, M. ;
Lynch, M. ;
Geese, W. J. ;
Kopit, J. ;
Shaw, J. W. ;
Gillison, M. L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) :1856-1867